Rep. Richard W. Allen discloses trade(s) in ABT, AMP, INTU, PG, SPGI
Richard W. Allen (GA12) disclosed 5 transactions, traded Apr 15 – Apr 16: 0 purchases and 5 sales.
| Traded | Ticker | Company | Action | Amount | Owner |
|---|---|---|---|---|---|
| Apr 16 | ABT | Abbott Laboratories | Sell | $15,001 - $50,000 | Spouse |
| Apr 16 | INTU | Intuit Inc. | Sell | $15,001 - $50,000 | Spouse |
| Apr 16 | PG | Procter & Gamble Company | Sell | $15,001 - $50,000 | Spouse |
| Apr 16 | SPGI | S&P Global Inc. | Sell | $15,001 - $50,000 | Spouse |
| Apr 15 | AMP | Ameriprise Financial, Inc. | Sell | $50,001 - $100,000 | Spouse |
ORIGINAL FILING ↗ALL FILINGS BY RICHARD W. ALLEN →CONGRESS TRADES DASHBOARD →
Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.
What This Means
A U.S. representative has filed a financial disclosure covering stock transactions in five companies spanning healthcare, financial services, software, consumer goods, and ratings sectors. Congressional stock trading disclosures are public records used to monitor potential conflicts of interest and insider trading risks. The specific holdings and transaction timing are available in the full disclosure document.
Sources — 1 tier
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- Hon. Richard W. AllenSep 26, 2026Rep. Richard W. Allen discloses trade(s) in ABT, AMP, INTU, PG, SPGI ↗
How This Could Play Out — recorded when first flagged, not updated
Resolve
LIKELYThis disclosure remains a routine administrative filing with no market impact, as congressional trading disclosures are standard public record and do not signal coordinated action or policy shifts affecting these sectors.
Left Unattended
LIKELYThe trades continue to be treated as routine personal portfolio management by a single legislator, with no media amplification or scrutiny that would draw broader market attention to the specific holdings or timing.
Escalate
UNLIKELYIf media or watchdog groups highlight the timing or pattern of these sales relative to pending legislation affecting healthcare, financial services, software, consumer goods, or credit rating agencies, it could fuel broader debate about congressional trading practices and potentially create reputational pressure on the legislator or sector-specific regulatory concerns.
SPONSORED
Confidence History
- HIGH CONFIDENCESep 27, 2026 at 6:19 PM
Legally mandated financial disclosure filing -- primary source, not a report about the event